Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US and EMEA name officers participating in staff exchange programme

This article was originally published in SRA

Executive Summary

The US Food and Drug Administration and the European Medicines Agency have reached a milestone in their international collaboration efforts. At the Drug Information Association’s 45th annual meeting in San Diego, US, on 24 June, the regulatory authorities named two officials that they have chosen to participate in the first-ever permanent staff exchange arrangement between the agencies. Karen Finn reports.

You may also be interested in...



Global medtech alliance approves six new member associations

An emerging alliance of medical technology industry associations representing innovative companies that currently develop and manufacture 85% of the world's medical devices, diagnostics and equipment has approved the membership applications of six more associations, bringing the total number of members to 19.

Global medtech alliance approves six new member associations

An emerging alliance of medical technology industry associations representing innovative companies that currently develop and manufacture 85% of the world's medical devices, diagnostics and equipment has approved the membership applications of six more associations, bringing the total number of members to 19.

US FDA scrutiny of DTC genetic tests continues

The US FDA's devices unit has written to three genetic testing companies warning them that they may be marketing their products and services without clearance by the agency.

UsernamePublicRestriction

Register

SC081785

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel